2022
Mitochondrial fitness and cancer risk
Kossenkov AV, Milcarek A, Notta F, Jang GH, Wilson JM, Gallinger S, Zhou DC, Ding L, Ghosh JC, Perego M, Morotti A, Locatelli M, Robert ME, Vaira V, Altieri DC. Mitochondrial fitness and cancer risk. PLOS ONE 2022, 17: e0273520. PMID: 36223343, PMCID: PMC9555630, DOI: 10.1371/journal.pone.0273520.Peer-Reviewed Original ResearchConceptsPancreatic ductal adenocarcinomaSenescence-Associated Secretory PhenotypeIndependent patient cohortsPoor patient outcomesAggressive disease variantFolfirinox failureLocal inflammationPatient cohortDuctal adenocarcinomaPatient outcomesPatient riskMultiple malignanciesCancer riskMitochondrial fitnessSecretory phenotypeGene signatureHallmarks of cancerMetastatic propensityNormal tissuesHuman tumorsInterferon SignalingTumorsInner membrane mitochondrial proteinMalignancyMolecular signaturesOpen-Capsule Budesonide for the Treatment of Isolated Immune Checkpoint Inhibitor-Induced Enteritis
Hussain N, Robert M, Al-Bawardy B. Open-Capsule Budesonide for the Treatment of Isolated Immune Checkpoint Inhibitor-Induced Enteritis. ACG Case Reports Journal 2022, 9: e00882. PMID: 36237281, PMCID: PMC9553371, DOI: 10.14309/crj.0000000000000882.Peer-Reviewed Original Research
2005
Squamous Cell Carcinoma of the Pancreas
Brown H, Dotto J, Robert M, Salem R. Squamous Cell Carcinoma of the Pancreas. Journal Of Clinical Gastroenterology 2005, 39: 915-919. PMID: 16208119, DOI: 10.1097/01.mcg.0000180636.74387.e6.Peer-Reviewed Original ResearchConceptsSquamous cell carcinomaCell carcinomaMetastatic diseaseEvidence of metastatic diseasePancreatic ductal epitheliumNegative marginsRare tumorSurgical resectionPancreatic malignancyBack painBloc resectionLymph nodesRare conditionPoor prognosisDuctal epitheliumCarcinomaResectionPancreasDiseaseMalignancyLymphPainPrognosisTumorEpithelium